Organization Overview
Alternative names
64cu-dota-daratumumab (1 trial)
abiraterone (zytiga) (2 trials)
anastrozole (arimidex) (1 trial)
apalutamide (erleada) (3 trials)
atezolizumab (tecentriq) (6 trials)
bevacizumab (avastin) (16 trials)
bicalutamide (casodex) (9 trials)
capecitabine (xeloda) (8 trials)
carboplatin (paraplatin) (40 trials)
cetuximab (erbitux) (8 trials)
cisplatin (platinol) (44 trials)
darolutamide (Nubeqa) (1 trial)
degarelix acetate (firmagon) (2 trials)
docetaxel (taxotere) (13 trials)
doxorubicin (Doxil) (14 trials)
durvalumab (imfinzi) (3 trials)
erlotinib (tarceva) (3 trials)
estramustine (emcyt) (1 trial)
etoposide (vepesid) (5 trials)
exemestane (aromasin) (1 trial)
filgrastim (neupogen) (7 trials)
flucytosine (ancobon) (1 trial)
fluorouracil (efudex) (11 trials)
flutamide (eulexin) (8 trials)
gemcitabine (gemzar) (13 trials)
goserelin (zoladex) (8 trials)
histrelin (supprelin) (2 trials)
ketoconazole (nizoral) (1 trial)
leuprolide (lupron) (7 trials)
memantine (namenda) (4 trials)
nilutamide (nilandron) (1 trial)
olaparib (lynparza) (8 trials)
ondansetron (zofran) (1 trial)
oxaliplatin (eloxatin) (6 trials)
paclitaxel (taxol) (54 trials)
pembrolizumab (keytruda) (6 trials)
pemetrexed (alimta) (3 trials)
pertuzumab (perjeta) (2 trials)
procarbazine (matulane) (2 trials)
sargramostim (leukine) (7 trials)
sitagliptin (januvia) (2 trials)
tamoxifen (nolvadex) (4 trials)
temozolomide (temodar) (15 trials)
topotecan (hycamtin) (6 trials)
trametinib (mekinist) (2 trials)
trastuzumab (herceptin) (5 trials)
triptorelin (Trelstar) (4 trials)
vinblastine (velban) (2 trials)
vincristine (oncovin) (2 trials)
alectinib (alecensa) (1 trial)
attenuated live listeria encoding hpv 16 e7 vaccine (1 trial)
binimetinib (mektovi) (1 trial)
bleomycin (blenoxane) (1 trial)
brigatinib (alunbrig) (1 trial)
bupropion (wellbutrin) (1 trial)
crizotinib (xalkori) (2 trials)
cytarabine (cytosar-u) (1 trial)
dasatinib (sprycel) (2 trials)
everolimus (zortress) (1 trial)
fludeoxyglucose f-18 (2 trials)
fulvestrant (faslodex) (2 trials)
gonadorelin (factrel) (1 trial)
lenvatinib (lenvima) (1 trial)
lidocaine (xylocaine) (1 trial)
lorlatinib (lorbrena) (1 trial)
medroxyprogesterone (provera) (1 trial)
mitomycin (mutamycin) (2 trials)
oxycodone (oxycontin) (1 trial)
pazopanib (votrient) (3 trials)
peg-pei-cholesterol lipopolymer-encased il-12 dna plasmid vector gen-1 (1 trial)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 2)
Adenocarcinoma, Clear Cell (Phase 3)
Adenocarcinoma, Mucinous (Phase 3)
Adenocarcinoma of Lung (Phase 2)
Adenomyoepithelioma (Phase 2)
Adenosarcoma (Phase 2)
Anus Neoplasms (Phase 2)
Astrocytoma (Phase 3)
Brain Neoplasms (Phase 3)
Breast Carcinoma In Situ (Phase 3)
Breast Neoplasms (Phase 3)
Brenner Tumor (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Acinar Cell (Phase 3)
Carcinoma, Adenosquamous (Phase 3)
Carcinoma, Ductal (Phase 3)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Endometrioid (Phase 3)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Small Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 3)
Carcinosarcoma (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Cholangiocarcinoma (Phase 3)
Choriocarcinoma (Phase 3)
Cognitive Dysfunction (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Cystadenocarcinoma (Phase 3)
Cystadenocarcinoma, Mucinous (Phase 3)
Cystadenocarcinoma, Serous (Phase 3)
Deglutition Disorders (Phase 2)
Endometrial Neoplasms (Phase 3)
Epstein-Barr Virus Infections (Phase 3)
Erectile Dysfunction (Phase 3)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Esophagitis (Phase 2)
Fallopian Tube Neoplasms (Phase 3)
Fatigue (Phase 3)
Fibrosis (Phase 2)
Gestational Trophoblastic Disease (Phase 3)
Glioblastoma (Phase 3)
Glioma (Phase 2)
Gliosarcoma (Phase 3)
Granulosa Cell Tumor (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hydatidiform Mole (Phase 3)
Hypersensitivity (Phase 2)
Infertility (Phase 3)
Laryngeal Diseases (Phase 3)
Laryngeal Neoplasms (Phase 3)
Leiomyosarcoma (Phase 3)
Leydig Cell Tumor (Phase 2)
Lip Neoplasms (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Mesothelioma (Phase 3)
Mixed Tumor, Mullerian (Phase 3)
Mouth Neoplasms (Phase 3)
Nasopharyngeal Carcinoma (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Nervous System Neoplasms (Phase 3)
Neurotoxicity Syndromes (Phase 3)
Oligodendroglioma (Phase 3)
Oropharyngeal Neoplasms (Phase 3)
Ovarian Neoplasms (Phase 3)
Pancreatic Intraductal Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 3)
Peritoneal Neoplasms (Phase 3)
Precancerous Conditions (Phase 3)
Prostatic Neoplasms (Phase 3)
Radiation Pneumonitis (Phase 2)
Rectal Neoplasms (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Endometrial Stromal (Phase 2)
Sertoli-Leydig Cell Tumor (Phase 2)
Sex Cord-Gonadal Stromal Tumors (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Thyroid Carcinoma, Anaplastic (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Tongue Neoplasms (Phase 3)
Trophoblastic Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Vaginal Neoplasms (Phase 2)
Virus Diseases (Phase 3)
Vulvar Neoplasms (Phase 2)
Xerostomia (Phase 3)